Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 310 participants.
Also called NCT02087540
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 310 participants
- Sponsor
- Registry
-
NCT02087540
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02087540. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
- Condition
- Hypertension
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Telmisartan 80mg
- Intervention (Drug)
- Rosuvastatin 20mg
- Intervention (Drug)
- Rosuvastatin 10mg
- Intervention (Drug)
- Placebo(for Telmisartan 80mg)
- Intervention (Drug)
- Placebo(for Rosuvastatin 20mg)
- Intervention (Drug)
- Placebo(for Rosuvastatin 10mg)
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
Record details
- Record id
cardio:ct-nct02087540- Content hash
ced2bc7dcdfda329fc4fac1014a34ea1d00d491bf0c6c679976a247b2320cb56